Pharma Press Releases
Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Sanofi and Regeneron's Dupixent approved in the United States as the first and only drug for allergic fungal rhinosinusitis
Wednesday, February 25, 2026The US Food and Drug Administration FDA has approved Dupixent dupilumab for the treatment of adult and pediatric patients years of age and older with allergic fungal rhinosinusitis AFRS who have a history
Hansa Biopharma’s Biologics License Application (BLA) for imlifidase accepted by the FDA
Tuesday, February 24, 2026Hansa Biopharma AB today announced that its Biologics License Application BLA for imlifidase has been accepted by the US Food and Drug Administration FDA
CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC
Tuesday, February 24, 2026CStone Pharmaceuticals an innovationdriven biopharmaceutical company focused on the research and development of therapies for oncology autoimmuneinflammation and other key disease areas today announced that
INTERPHEX WEEK TOKYO to Expand Its 2026 Showcase as Japan’s Largest Pharma and Biotech Gathering
Tuesday, February 24, 2026INTERPHEX WEEK TOKYO one of Japans largest and most influential trade shows for the pharmaceutical and biotechnology sectors is set to return May at Makuhari Messe with an expanded showcase expected to surpass its performance and deliver a more dy...
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
Saturday, February 21, 2026Genentech a member of the Roche Group announced today that the US Food and Drug Administration FDA has accepted the companys New Drug Application for giredestrant an investigational oral therapy
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
Saturday, February 21, 2026Savara Inc a clinicalstage biopharmaceutical company focused on rare respiratory diseases announced the FDA has filed for review the BLA for MOLBREEVI as a therapy to treat patients with autoimmune PAP
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
Saturday, February 21, 2026Zelluna a company pioneering allogeneic offtheshelf T Cell Receptorbased Natural Killer TCRNK cell therapies for the treatment of solid cancers today announced that the Medicines and Healthcare products Regulatory
Asahi Kasei Pharma selects MAIA Pharmaceuticals to Advance Teribone™ for U.S. osteoporosis patients
Friday, February 20, 2026Asahi Kasei Pharma announces that it has selected MAIA Pharmaceuticals Inc as its US partner under a strategic collaboration for the development and commercialization in the US of Teribone osteoporosis drug
SEQSTER Launches 1-Click Data Refinery™ to Power Scalable AI Across Clinical Trials
Friday, February 20, 2026SEQSTER PDM Inc the leading healthcare technology company and the data connection collection and orchestration layer for patient health data today announced the launch of Click Data Refinery an enterprisegrade data
PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
Friday, February 20, 2026PureTech Health plc a hubandspoke biotherapeutics company dedicated to giving life to science and transforming innovation into value today announced that the US Food and Drug Administration FDA and European Commission
